Animalia Biopharmaceuticals Llp - Company Profile

It is a home appliances limited liability partnership based in Bangalore, Karnataka, India, established in 2021.
2021 Bangalore, Karnataka, India Active
Last Updated:
Access Report
About Animalia Biopharmaceuticals Llp

Animalia Biopharmaceuticals Llp, a active limited liability partnership, was established on 18 February 2021 in Bangalore, Karnataka, India. Engaging in repair of personal and household goods within the home appliances sector, it holds LLPIN: AAV-9603. Registered under ROC Roc Bangalore. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Karkhanis Sandeep Sadashiv (Designated Partner), Sneha Sandeep Karkhanis (Designated Partner). Its latest date of accounts and solvency statement 31 March 2023. It is based at B 18, Sobha Emerald, Behind Jakkur Flying Club,Jakkur, Bangalore, Karnataka, 560064.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAV-9603

  • Incorporation Date

    18 February 2021

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Bangalore

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 5 Year, 7 Days
  • Last Filing with ROC 31 Mar 2023
Company report

Animalia Biopharmaceuticals Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Animalia Biopharmaceuticals Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Animalia Biopharmaceuticals Llp?
Current Designated Partners
Name Designation Appointment Date Status
Karkhanis Sandeep Sadashiv Designated Partner 18 Feb 2021 Current
Sneha Sandeep Karkhanis Designated Partner 18 Feb 2021 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Animalia Biopharmaceuticals Llp.

Enhance accessibility to Animalia Biopharmaceuticals Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Animalia Biopharmaceuticals Llp revenue growth over time
Animalia Biopharmaceuticals Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Animalia Biopharmaceuticals Llp?

Unlock access to Animalia Biopharmaceuticals Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Animalia Biopharmaceuticals Llp?

Unlock and access historical data on people associated with Animalia Biopharmaceuticals Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Animalia Biopharmaceuticals Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Animalia Biopharmaceuticals Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Animalia Biopharmaceuticals Llp
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Animalia Biopharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2024 as per latest MCA records. was documented.

  • Statement of Assets & Liabilities

    The activity Animalia Biopharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.

  • Director Appointment

    Progress on Karkhanis Sandeep Sadashiv was appointed as a Designated Partner was appointed as a Designated Partner on 18 Feb 2021 & has been associated with this company since 5 years 7 days . was documented.

  • Director Appointment

    The activity Sneha Sandeep Karkhanis was appointed as a Designated Partner was appointed as a Designated Partner on 18 Feb 2021 & has been associated with this company since 5 years 7 days . was completed.

  • LLP Incorporation

    Progress on Animalia Biopharmaceuticals Llp was registered on 18 Feb 2021 with Roc Bangalore & aged 5 years 7 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Animalia Biopharmaceuticals Llp?

The LLPIN of Animalia Biopharmaceuticals Llp is AAV-9603.

Where is Animalia Biopharmaceuticals Llp headquartered?

Animalia Biopharmaceuticals Llp is headquartered at B 18, Sobha Emerald, Behind Jakkur Flying Club,Jakkur, Bangalore, Karnataka, 560064.

When was Animalia Biopharmaceuticals Llp incorporated?

Animalia Biopharmaceuticals Llp was incorporated on 18 February 2021.

Who are the current directors of Animalia Biopharmaceuticals Llp?

The current directors of Animalia Biopharmaceuticals Llp are

What is the primary industry of Animalia Biopharmaceuticals Llp?

The primary industry of Animalia Biopharmaceuticals Llp is Home Appliances.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available